Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases

Cornford, 2017, EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer, Eur Urol, 71, 630, 10.1016/j.eururo.2016.08.002 Tzelepi, 2011, Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment, J Clin Oncol, 29, 2574, 10.1200/JCO.2010.33.2999 Cifuentes, 2015, Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer, Oncol Rep, 34, 2837, 10.3892/or.2015.4319 Heidenreich, 2015, Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study, J Urol, 193, 832, 10.1016/j.juro.2014.09.089 Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor?. A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012 Sooriakumaran, 2015, A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation, Eur Urol, 69, 788, 10.1016/j.eururo.2015.05.023 Gratzke, 2014, Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry, Eur Urol, 66, 602, 10.1016/j.eururo.2014.04.009 Fossati, 2015, Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study, Eur Urol, 67, 3, 10.1016/j.eururo.2014.08.056 Steuber T, Berg KD, Røder MA, et al. Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case-control study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2017.06.016. Leyh-Bannurah, 2017, Local therapy improves survival in metastatic prostate cancer, Eur Urol, 72, 118, 10.1016/j.eururo.2017.03.020 Heidenreich, 2001, Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy in prostate cancer: high incidence of lymph node metastases, J Urol, 167, 1681, 10.1016/S0022-5347(05)65177-4 Moschini, 2017, Treatment of M1a/M1b prostate cancer with or without radical prostatectomy at diagnosis, Prostate Cancer Prostatic Dis, 20, 117, 10.1038/pcan.2016.63 Sweeney, 2015, Chemohormonal therapy in metastatic hormone-sensitive prostate cancer, N Engl J Med, 373, 737, 10.1056/NEJMoa1503747 James, 2016, Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial, Lancet, 387, 1163, 10.1016/S0140-6736(15)01037-5 Gundem, 2015, The evolutionary history of lethal metastatic prostate cancer, Nature, 520, 353, 10.1038/nature14347 Rusthoven, 2016, Improved survival with prostate radiation in addition to androgen deprivation therapy for men with newly diagnosed metastatic prostate cancer, J Clin Oncol, 34, 2835, 10.1200/JCO.2016.67.4788 Joensuu, 2016, Multimodal primary treatment of metastatic prostate cancer with androgen deprivation and radiation, Anticancer Res, 36, 6439, 10.21873/anticanres.11242 Hussain, 2006, Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162), J Clin Oncol, 24, 3984, 10.1200/JCO.2006.06.4246 Poelaert, 2017, Cytoreductive prostatectomy for metastatic prostate cancer: first lessons learned from the multicentric prospective LoMP trial, Urology, 106, 146, 10.1016/j.urology.2017.02.051 Kim, 2018, Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study, Asian J Androl, 20, 9, 10.4103/1008-682X.196852 Suardi, 2013, Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery, BJU Int, 111, 717, 10.1111/j.1464-410X.2012.11315.x Joniau, 2012, Complications and functional results of surgery for locally advanced prostate cancer, Adv Urol., 2012, 706309, 10.1155/2012/706309 Neeman, 2013, Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement, Brain Behav Immun, 30, S32, 10.1016/j.bbi.2012.03.006 Won, 2013, Primary treatment of the prostate improves local palliation in men who ultimately develop castrate resistant prostate cancer, BJU Int, 112, E250, 10.1111/bju.12169 Aus, 1995, Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent, J Urol, 154, 466, 10.1016/S0022-5347(01)67075-7